GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.
A University of Barcelona study hows that two approved drugs reduce fat accumulation in the liver of animal models of metabolic liver disease. Above, from left to right, Juan Carlos Laguna, Patricia ...
Latest research based on animal model trials shows GLP-1 drugs may prevent problem of ‘no-reflow’ in recovery ...
Liver disease is the new “silent killer” that’s quietly becoming one of the world’s biggest health concerns. The most common type among different kinds of liver diseases, fatty liver disease, is ...